BP435

Naproxen

British Pharmacopoeia (BP) Reference Standard

• Synonym(s): (S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid
• Linear Formula: CH₃OC₁₀H₆CH(CH₃)CO₂H
• CAS Number: 22204-53-1
• Molecular Weight: 230.26
• Beilstein: 3591068
• Número de EC: 244-838-7
• Número MDL: MFCD00010500
• NACRES: NA.24

Properties

• grado: pharmaceutical primary standard
• manufacturer/tradename: BP
• mp: 152-154 °C (lit.)
• formato: neat
• temp. de almacenamiento: 2-8°C
• SMILES string: COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O
• InChI: 1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1
• InChI key: CMWTZPSULFXXJA-VIFPVBQESA-N
• Gene Information: human ... PTGS1(5742) , PTGS2(5743)

Description

Descripción general

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Envase

100 mg

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Acciones bioquímicas o fisiológicas

Non-selective cyclooxygenase (COX-1 and COX-2) inhibitor.

Otras notas

Sales restrictions may apply.

Safety Information

• pictogramas: GHS07,GHS08,GHS09
• Palabra de señalización: Warning
• Frases de peligro: H302 - H315 - H319 - H335 - H361fd - H411
• Consejos de prudencia: P202 - P273 - P301 + P312 - P302 + P352 - P305 + P351 + P338 - P308 + P313
• Clasificaciones de peligro: Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT SE 3
• Órganos de actuación: Respiratory system
• Código de clase de almacenamiento: 11 - Combustible Solids
• WGK: WGK 3